Debut Plus

₹431.2

▼ -28.26 -6.15%

17 Jul 2026

NSE Listed

Fermenta Biotech Ltd. (FERMENTA)

Volume: 1,49,942Avg Vol 1W: 5,77,152.4Avg Vol 1M: 4,97,447.9552W Range:₹248.85₹479.45
NSE BSE www.fermentabiotech.com
Key Ratios
Checked 6h ago
Market Cap₹1,352 Cr
Current Price₹431.2
Previous Close₹459.46
High / Low (52w)₹479.45 / ₹248.85
Volume1,49,942
Avg Vol (1W)5,77,152.4
Avg Vol (1M)4,97,447.95
Stock P/E20.27
Book Value₹138.15
Dividend Yield79%
ROE17.67%
ROA10.84%
Revenue (TTM)₹481 Cr
Revenue Growth—
Profit Margin13.66%
Total Debt₹15 Cr
Shares Outstanding3 Cr
Face Value₹5
EPS (TTM)₹22.67
P/B3.33
Debt / Equity0.39
50 DMA₹345.87
200 DMA₹335.38
Day change-6.15%
Price Chart
₹431.2▲ 35.43% · 1Y
₹455₹28131.4L
2026-04-20
2026-07-16

20-day avg volume: 5.0L shares

Pros
  • Healthy return on equity of 17.7%.
  • Pays a dividend yield of 79.0%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Revenue fell 21% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹78 Cr₹95 Cr₹156 Cr₹140 Cr₹136 Cr₹130 Cr₹137 Cr₹122 Cr
EBITDA₹-2 Cr₹16 Cr₹49 Cr₹35 Cr₹31 Cr₹27 Cr₹23 Cr₹20 Cr
Net Profit₹-6 Cr₹11 Cr₹37 Cr₹34 Cr₹22 Cr₹18 Cr₹13 Cr₹19 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹311 Cr₹416 Cr₹304 Cr₹386 Cr₹407 Cr₹359 Cr₹347 Cr₹481 Cr
EBITDA₹90 Cr₹149 Cr₹63 Cr₹70 Cr₹44 Cr₹-2 Cr₹15 Cr₹97 Cr
Net Profit₹36 Cr₹117 Cr₹60 Cr₹46 Cr₹15 Cr₹-51 Cr₹-23 Cr₹77 Cr
EPS155.6340.720.5315.695.35-17.7-7.9926.35
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹387 Cr₹551 Cr₹614 Cr₹687 Cr₹707 Cr₹637 Cr₹548 Cr₹614 Cr
Total Liabilities₹249 Cr₹301 Cr₹304 Cr₹327 Cr₹335 Cr₹324 Cr₹263 Cr₹256 Cr
Equity₹137 Cr₹251 Cr₹309 Cr₹360 Cr₹371 Cr₹313 Cr₹285 Cr₹359 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹78 Cr₹123 Cr₹48 Cr₹76 Cr₹53 Cr₹113 Cr₹104 Cr₹44 Cr
Investing₹-101 Cr₹-97 Cr₹-44 Cr₹-42 Cr₹-26 Cr₹-55 Cr₹-15 Cr₹0 Cr
Financing₹89 Cr₹12 Cr₹-47 Cr₹-1 Cr₹-22 Cr₹-41 Cr₹-91 Cr₹-51 Cr
Free Cash Flow₹78 Cr₹123 Cr₹48 Cr₹76 Cr₹53 Cr₹113 Cr₹104 Cr₹44 Cr
Shareholding
Promoter 64.09% Institutions 0.03% Public 35.89%
Efficiency & Working Capital
ROCE20%
Interest Coverage6.6
Dividend Payout—
Debtor Days74 d
Inventory Days96 d
Payable Days60 d
Cash Conversion Cycle110 d
Working Capital Days170 d
Shareholding Details

As of 2026-03-31

Promoter64.1%
FII0%
DII0%
Institutions0%
Public35.9%
Promoter Pledge0%
No. of Shareholders13,661
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters62.1%62.1%62.1%62.1%62.1%62.1%62.1%64.1%64.1%64.1%64.1%64.1%
FIIs0%0%0%0%0%0.1%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public37.9%37.9%37.9%37.9%37.9%37.9%37.9%35.9%35.9%35.9%35.9%35.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders16,14815,72115,15015,17814,58913,22112,92212,93012,84513,76014,13913,661
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Krishna DatlaShareholding of Promoter and Promoter Group36%1.06 Cr
Satish Varma Azad NadimpallyShareholding of Promoter and Promoter Group11.7%34,53,325
Anupama Datla DesaiShareholding of Promoter and Promoter Group8.7%25,61,265
Preeti ThakkarShareholding of Promoter and Promoter Group7.6%22,40,376
Rakesh Kantilal ShahPublic Shareholding1.8%5,40,432
Krishan Premnarayen .Public Shareholding1.4%4,05,000
Hima Pathak .Public Shareholding1%3,00,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Krishna Datla00%2026-03-31
Satish Varma Azad Nadimpally00%2026-03-31
Anupama Datla Desai00%2026-03-31
Preeti Thakkar00%2026-03-31
Hima Pathak .00%2026-03-31
Krishan Premnarayen .00%2026-03-31
Rakesh Kantilal Shah00%2026-03-31
Krishna Datla00%2025-12-31
Satish Varma Azad Nadimpally00%2025-12-31
Anupama Datla Desai00%2025-12-31
Preeti Thakkar00%2025-12-31
Hima Pathak .00%2025-12-31
Board of Directors
NameDesignationYear
Satish VarmaExecutive Director2025
Srikant N SharmaCompany Sec. & Compli. Officer2025
Krishna DatlaExecutive Vice Chairman2025
Rajeshwari DatlaNon Executive Director2025
ANUPAMA DATLA DESAIExecutive Director2025
Rajashri Santosh Kumar OjhaIndependent Director2025
Prashant NagreManaging Director2025
Pramod KasatIndependent Director2025
Pradeep Manjunath ChandanChairman & Independent Director2025
Ramanand MundkurIndependent Director2025
Segments — Product
SegmentRevenueShare
Bulk Drug/ Chemicals₹361 Cr86.9%
Property₹54 Cr13.1%
Segments — Geography
RegionRevenueShare
India₹220 Cr49.7%
Europe₹113 Cr25.6%
USA₹38 Cr8.7%
Others countries₹71 Cr16%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹5321515
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-05Dividend (3.75/- per share)Final
dividend2025-08-06₹2.5 (50%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025470015063
2025000000
202500015015
Insider / Designated-Person Trades

8 recent disclosure(s)

Rajeshwari DatlaDisposal · 5,95,818
Krishna DatlaAcquisition · 5,95,818
Prashant NagreDisposal · 11,000
Prashant NagreDisposal · 67,000
Rajeshwari DatlaAcquisition · 84,400
Krishna DatlaAcquisition · 42,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Off Market26/03/2025 · 5,95,818
Company Information
Incorporated1951
ChairmanPradeep Manjunath Chandan
AuditorS R B C & Co LLP
Investor Email[email protected]; [email protected]
🌐 www.fermentabiotech.com ↗

📍 A-1501 DIL Complex Majiwada, Ghodbunder Road Thane One, Thane (West), Maharashtra, 400610

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

FDCFedders Holding Ltd.Federal Bank Ltd.Fedbank Financial Ser LimitedFuture Enterprises Ltd.Felix Industries Ltd.FiberwebFidel Softech LimitedFiem Industries LimitedFilatex India Ltd.Filatex Fashions LimitedFinbud Financial Serv Ltd.All “F” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search